Skip to content
Search

Latest Stories

Nearly half of UK employers plan to cut office space as remote working gains popularity

ROUGHLY half of UK's employers are planning to reduce office space and stagger return to work as Britain eases restrictions following a three-month lockdown, according to a survey by recruiter Robert Walters.

Remote working will become more prevalent in a post-Covid world, the survey showed, as companies assess cost savings as well as health risks to staff.


Around 44 per cent of employers are considering cutting down physical office space and 49 per cent are planning to spread out employees' return to work, said the survey which polled 2,200 companies.

Last week, Britain's financial services minister said some banks would cut office space in London's financial district as they "reset" their operations.

Several companies across the world have extended work from home options for their staff, with US social media giant Facebook saying last month it will permanently embrace remote work even after lockdowns ease.

"It can be daunting for companies who have been going through a difficult period to consider spending money on their physical workspace, technical infrastructure or general operations," said Robert Walters director Lucy Bisset.

Three-quarters of British employers admitted that their senior team had not been equipped to manage teams remotely, and would need new training to adapt, the survey added.

It also found that 87 per cent of employees would like more opportunities to work from home post-return, and 21 per cent stated that they would like to work from home permanently.

Homebuyers were already showing in interest in buying bigger houses with better home workspace and gardens, major housebuilder Redrow noted on Tuesday (30).

More For You

 Ozempic

Novo Nordisk launches Ozempic in India as diabetes cases climb

Getty Images

Novo Nordisk launches Ozempic in India as type 2 diabetes and obesity cases surge

Highlights:

  • Novo Nordisk is selling Ozempic in India now.
  • Smallest pen, 0.25 mg – about £20.59 (₹2,200) a week (four doses in a pen)
  • Bigger pens – half a mg and 1 mg – cost around £95.18 (₹10,170) and £104.58 (₹11,175)
  • Only specialists can prescribe it – endocrinologists or internal medicine doctors.

Novo Nordisk has started selling Ozempic in India. The smallest weekly pen, 0.25 mg, costs around £20.59 (₹2,200). That covers four doses. Doctors say it lowers blood sugar. Some patients also lose weight. The bigger pens – 0.5 mg and 1 mg – cost about £95.18 (₹10,170) and £104.58 (₹11,175) per month.

 Ozempic Novo Nordisk launches Ozempic in India as diabetes cases climb Getty Images

Keep ReadingShow less